biotech
biotech Articles
Zynerba Pharmaceuticals shares jumped on Tuesday after the company announced that it has received a key patent from the U.S. Patent and Trademark Office.
Published:
Last Updated:
Investors and speculators just love a good merger and acquisition story. The story of General Electric selling its Life Sciences biotechnology instrument division to Danaher is one of those fairy...
Published:
Last Updated:
Spark Therapeutics shares more than doubled in Tuesday’s session as the result of its pending acquisition. However, the root of the buyout was its gene therapy, which could drive more acquisitions...
Published:
Last Updated:
Spark Therapeutics shares more than doubled to start out the week after the company announced that it would be acquired by Swiss health care giant Roche, which is looking to add to its portfolio.
Published:
Last Updated:
Voyager Therapeutics shares made an incredible gain on Friday after the firm announced a collaboration with pharma giant AbbVie.
Published:
Last Updated:
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Published:
Last Updated:
Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid in patients with liver fibrosis due to nonalcoholic...
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data have been compared with the previous report, and short interest in...
Published:
Last Updated:
It's another disappointing day for one of America's top biotech companies. But that may prove to be great news for Intercept Pharmaceuticals.
Published:
Last Updated:
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
Published:
Last Updated:
Solid Bio shares were absolutely crushed on Thursday after preliminary data from the firm’s midstage trial in Duchenne muscular dystrophy was not up to par.
Published:
Last Updated:
MacroGenics shares absolutely exploded on Wednesday after the firm announced late-stage results for its breast cancer trial.
Published:
Last Updated:
Gilead Sciences is living up to our theory that Big Biotech is now effectively the same as Big Pharma.
Published:
Last Updated:
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
Published:
Last Updated:
There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,...
Published:
Last Updated: